- Pharming Group N.V. (Euronext: PHARM/Nasdaq: PHAR) to release Q1 2025 financial results on May 8, 2025.
- The earnings report will cover the fiscal period ending March 31, 2025.
- An analyst and investor presentation will be held at 13:30 CEST/07:30 EDT on the same day.
Pharming Group N.V. (PHARM, Financial) has announced its plan to publish the preliminary, unaudited financial results for the first quarter of 2025 on Thursday, May 8, 2025. The financial report will encapsulate the company's performance for the period ending March 31, 2025.
In conjunction with the earnings release, Pharming will conduct a presentation for analysts and investors on the same day at 13:30 CEST/07:30 EDT. Stakeholders interested in participating are required to register in advance through the provided conference call link. The company has stipulated that questions will be entertained only from dial-in participants who have registered beforehand.
Pharming Group N.V., headquartered in Leiden, the Netherlands, is a global biopharmaceutical company committed to innovating treatments for rare, debilitating, and life-threatening diseases. The company's portfolio includes the development and commercialization of advanced small molecules and biologics. Pharming serves patients across more than 30 markets worldwide, spanning North America, Europe, the Middle East, Africa, and the Asia-Pacific region.
